Pharmaceuticals

One year after the nation learned of the Supreme Court’s intent to peel back federal protections for abortions via a

The Phase II trial will study OK-101 to treat dry eye disease. Credit: megaflopp via Shutterstock. OKYO Pharma has screened

Sen. Bernie Sanders (I-Vt.) has indicated he could block President Biden’s likely pick to head the National Institutes of Health

Source: GlobalData, Pharma Intelligence Center (Accessed 26 March 2023). © GlobalData According to GlobalData’s Clinical Trials Database, among clinical trials

On May 1, 2023, Bausch Health Companies (TSE:BHC) remained firmly embedded in the minds of market analysts following its impressive

Europe, including Switzerland, has faced worsening drug shortages over the last few years. © Keystone / Christian Beutler Switzerland is

  …As NIPRD, Bloom, launches project By Doris Obinna   Director general/chief executive officer, Institute for Pharmaceutical Research and Development

In a move that will be immense benefit to thousands of pharmaceutical companies in the country, the national drug regulator,

As senior figures from the UK biopharma industry gathered in a gloomy London for the Annual Conference of The Association

If you are the site owner (or you manage this site), please whitelist your IP or if you think this